loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1998_037___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Tasmanian Alkaloids Pty Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Tasmanian Alkaloids Pty Ltd Westbury AU (1)

    filter

    01 Buprenorphine (1)

    filter

    01 Australia (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Tasmanian Alkaloids Pty Ltd Westbur...

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Australia
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Buprenorphine

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1998-037 - Rev 03
    Withdrawn by Holder
    Chemical
    2016-07-22
    2018-10-11
    1180
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1998-037 - Rev 03 of Tasmanian Alkaloids Pty Ltd Westbury Au

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1998-037 - Rev 03 of Tasmanian Alkaloids Pty Ltd Westbury Au 1

    20

    Tasmanian Alkaloids Pty Ltd Westbury Au, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Buprenorphine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-037 - Rev 03

    This Chemical Type CEP, issued on July 22, 2016, remains in force until October 11, 2018, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1180 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY